Temasek leads $65m Series B round for US-based bioscience firm Brightseed

Temasek leads $65m Series B round for US-based bioscience firm Brightseed

Nguyen Thi Bich Ngoc

11 May, 2022

Brightseed Temasek

Printed by Unregistered user on Wed, 13 Aug 2025 12:59:33 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

India: TPG Growth, Temasek invest $136m in Dr Agarwal's, ADV Partners exits

Temasek, Abu Dhabi Growth Fund back Upside Foods at over $1b valuation

Read more from Singapore

Temasek issues USD bonds to fund business operations

SEA Digest: Antler invests $7.4m in H1; CMC Corp, Samsung C&T team up for data centres